Related Experiment Video
Updated: Jul 19, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis
Pei-Yin Hsu1, Hsiao-Sheng Liu, Hong-Lin Cheng
1Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan, Republic of China.
Purpose:
Collaboration of heterologous receptor tyrosine kinases has emerged as an important paradigm in tumor progression. We recently proved that RON has an important role in human bladder carcinogenesis. Since epidermal growth factor receptor has been suggested to cross-talk with RON, we examined the significance of epidermal growth factor receptor in modulating RON associated tumorigenesis.
Materials And Methods:
The biological significance of collaboration between RON and epidermal growth factor receptor was examined in the TSGH8301, J82 and JR bladder cancer cell lines with different expression status. Immunoprecipitation and immunoblotting assays were done to investigate the interaction of RON with epidermal growth factor receptor in relation to epidermal growth factor receptor kinase inhibitor treatment. Time lapse wound healing monitoring and Transwelltrade mark assay were used for cell migration analysis and the effect on cell transformation was analyzed with foci formation assay. Finally, a bladder cancer cohort of 78 patients was studied for clinical significance by immunohistochemistry.
Results:
Epidermal growth factor receptor was directly associated with RON, irrespective of ligand stimulation. The siRNA experiment and epidermal growth factor receptor kinase inhibitors efficiently inhibited RON related biological effects, including mitogenesis, migration, anti-apoptosis and neoplastic transformation. Co-expression of RON/epidermal growth factor receptor was found in 26 of 78 patients (33.3%) with bladder cancer. It was significantly associated with tumor invasion (p < 0.05), the risk of local recurrence (p = 0.0003) and decreased patient survival (p = 0.04). Important indicators for patient survival were co-expression of RON and epidermal growth factor receptor (p = 0.001) and tumor staging (p = 0.05).
Conclusions:
Cross-talk between epidermal growth factor receptor and RON exists in vivo. Thus, it should be considered in treatment planning for patients with bladder cancer.
Insights
Epidermal growth factor receptor (EGFR) and RON receptor tyrosine kinase collaborate in bladder cancer progression. Inhibiting EGFR blocks RON-driven tumor growth, invasion, and recurrence, suggesting combined targeting for improved patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Receptor tyrosine kinases (RTKs) play crucial roles in cancer development.
- RON, a specific RTK, is implicated in human bladder carcinogenesis.
- Cross-talk between RTKs, like EGFR and RON, is a key mechanism in tumor progression.
Purpose of the Study:
- To investigate the significance of epidermal growth factor receptor (EGFR) in modulating RON-associated bladder tumorigenesis.
- To elucidate the biological impact of the collaboration between RON and EGFR in bladder cancer.
- To assess the clinical relevance of RON and EGFR co-expression in a bladder cancer patient cohort.
Main Methods:
- Examined RON-EGFR interaction in bladder cancer cell lines (TSGH8301, J82, JR) using immunoprecipitation and immunoblotting.
- Assessed cell migration via time-lapse wound healing and Transwell assays.
- Analyzed cell transformation using foci formation assays.
- Investigated clinical significance through immunohistochemistry in a cohort of 78 bladder cancer patients.
Main Results:
- EGFR directly associates with RON, independent of ligand stimulation.
- EGFR inhibition (siRNA or kinase inhibitors) suppressed RON-driven mitogenesis, migration, anti-apoptosis, and neoplastic transformation.
- Co-expression of RON and EGFR was observed in 33.3% of patients (26/78).
- RON/EGFR co-expression correlated significantly with tumor invasion, local recurrence risk, and decreased patient survival.
- Combined RON/EGFR expression and tumor staging were critical indicators of patient survival.
Conclusions:
- A functional cross-talk exists between EGFR and RON in bladder cancer in vivo.
- The EGFR-RON axis represents a potential therapeutic target for bladder cancer.
- Considering this interaction in treatment planning may improve outcomes for bladder cancer patients.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
